Add a Comment By Media Staff   |  Monday, January 7, 2013 The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan-Kettering researchers. read more

More:
Projects Led by Memorial Sloan-Kettering Investigators Listed among Top Cancer Advances of 2012